New patent for Boehringer Ingelheim drug OFEV

Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Boehringer Ingelheim drug OFEV appeared first on Drug…


Biotechblog